Cargando…

The Effect of Supplementation with Low Doses of a Cod Protein Hydrolysate on Satiety Hormones and Inflammatory Biomarkers in Adults with Metabolic Syndrome: A Randomized, Double-Blind Study

Metabolic syndrome (MetS) is characterised by metabolic abnormalities that increase the risk of developing type 2 diabetes mellitus and cardiovascular disease. Altered levels of circulating ghrelin, several adipokines and inflammatory markers secreted from adipose tissue, such as leptin, adiponectin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Caroline, Dale, Hanna Fjeldheim, Hausken, Trygve, Hatlebakk, Jan Gunnar, Brønstad, Ingeborg, Lied, Gülen Arslan, Hoff, Dag Arne Lihaug
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695186/ https://www.ncbi.nlm.nih.gov/pubmed/33171589 http://dx.doi.org/10.3390/nu12113421

Ejemplares similares

Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: a double-blind cross-over trial
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2018)

Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: a double-blind cross-over trial — CORRIGENDUM
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Supplementation with Low Doses of a Cod Protein Hydrolysate on Glucose Regulation and Lipid Metabolism in Adults with Metabolic Syndrome: A Randomized, Double-Blind Study
por: Jensen, Caroline, et al.
Publicado: (2020)

Acute effect of a cod protein hydrolysate on postprandial acylated ghrelin concentration and sensations associated with appetite in healthy subjects: a double-blind crossover trial
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Supplementation with cod protein hydrolysate in older adults: a dose range cross-over study
por: Jensen, Caroline, et al.
Publicado: (2019)

Assessment of Markers of Gut Integrity and Inflammation in Non-Celiac Gluten Sensitivity After a Gluten Free-Diet
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2021)

The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study
por: Mazzawi, Tarek, et al.
Publicado: (2022)

Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives
por: FJELDHEIM DALE, Hanna, et al.
Publicado: (2020)

The effect of low dose marine protein hydrolysates on short-term recovery after high intensity performance cycling: a double-blinded crossover study
por: Mjøs, Ingunn, et al.
Publicado: (2019)

Correction to: The effect of low dose marine protein hydrolysates on short-term recovery after high intensity performance cycling: a double-blinded crossover study
por: Mjøs, Ingunn, et al.
Publicado: (2020)

Effects of Plant-Based Diets on Weight Status: A Systematic Review
por: Tran, Elisabeth, et al.
Publicado: (2020)

Effects of Plant-Based Diets on Outcomes Related to Glucose Metabolism: A Systematic Review
por: Johannesen, Christina Osland, et al.
Publicado: (2020)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2020)

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2021)

Altered levels of cytokines in patients with irritable bowel syndrome are not correlated with fatigue
por: Vara, Ellen Johanne, et al.
Publicado: (2018)

A psychological symptom based machine learning model for clinical evaluation of irritable bowel syndrome
por: Haleem, Noman, et al.
Publicado: (2023)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Increased wall thickness using ultrasonography is associated with inflammation in an animal model of experimental colitis
por: Lied, Gülen Arslan, et al.
Publicado: (2012)

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Density of Musashi-1-positive stem cells in the stomach of patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome
por: Berentsen, Birgitte, et al.
Publicado: (2020)

Intestinal barrier integrity in anorexia nervosa (a pilot study)
por: Kleppe, Malin M., et al.
Publicado: (2022)

Interaction between diet and gastrointestinal endocrine cells
por: EL-SALHY, MAGDY, et al.
Publicado: (2016)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Stomach antral endocrine cells in patients with irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

The role of peptide YY in gastrointestinal diseases and disorders
por: EL-SALHY, MAGDY, et al.
Publicado: (2013)

Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Gut Microbiota and Fecal Microbiota Transplantation in Patients with Food Allergies: A Systematic Review
por: Jensen, Caroline, et al.
Publicado: (2022)

Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2014)

Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Assessment of Self-Reported Executive Function in Patients with Irritable Bowel Syndrome Using a Machine-Learning Framework
por: Lundervold, Astri J., et al.
Publicado: (2023)

Gastroparesis Symptoms Associated with Intestinal Hypomotility: An Explorative Study Using Wireless Motility Capsule
por: Bekkelund, Mattis, et al.
Publicado: (2021)

Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis
por: El-Salhy, Magdy, et al.
Publicado: (2012)

Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
por: von Volkmann, Hilde L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0ncls1lkqttg83mt66msi2qpts